In mice, in vitro expansion of highly cytotoxic CD8+NK1.1+ T cells derived from bone marrow, spleen, and thymus have been shown to mediate strong anti-leukemia effects without GVHD after allogeneic transplantation (68, 69). This evidence concerns the gene CD8A and graft versus host disease.